• Comprehensive, patient-centered decision-making Integrate diverse expert opinions—medical, radiation, surgical oncology, pathology, radiology, nursing, palliative care, psychology, nutrition, social work—to develop personalized, evidence-based treatment plans that address the whole spectrum of patient needs and preferences. • Accurate diagnosis and staging Ensure precise assessment of disease through cross-specialty review of pathology and imaging, which is critical for selecting the appropriate treatment pathway. • Optimized treatment planning Evaluate and compare all viable options—including surgery, systemic therapies, radiotherapy, and clinical trials—to determine the best treatment sequence and modality for each patient. • Coordination of care Facilitate smooth communication across all involved disciplines, reducing delays, duplication, and treatment errors while ensuring timely interventions. • Supportive and holistic care Incorporate psychosocial, nutritional, geriatric, and rehabilitative support into treatment plans to enhance patients’ quality of life and address non-medical determinants of outcomes. • Improved clinical outcomes Evidence shows MDT involvement leads to better survival, lower relapse rates, and increased patient satisfaction in cancers such as lung, breast, colorectal, and prostate. • Efficient use of resources Streamline meeting time and healthcare resources by focusing in-depth discussion on complex cases while managing straightforward cases through standard pathways. • Facilitation of clinical trials & innovation Identify eligible patients for clinical research and incorporate emerging treatments and molecular insights—crucial for precision oncology. • Quality assurance and continuous improvement Monitor outcomes, audit decision-making processes, and adopt best practices to ensure consistent, high-quality team performance.